This marks a significant milestone for AtaiBeckley and positions us to advance BPL003 into Phase 3 studies in Q2 2026
I cant describe how much I recommend this to everyone with anxiety
Diabetes Obes Metab (2022) 24(1):14853
Benefits of Lifelong Use Sustained appetite control and hunger reduction Continued prevention of weight regain Lower risk of obesity-related complications (e.g., diabetes, heart disease) Potential Challenges Ongoing injection therapy requirements Possible side effects such as gastrointestinal discomfort Access and insurance coverage variability Cost considerations (which your healthcare provider can help navigate) Alternatives and Complementary Supports For those exploring options beyond Wegovy, other GLP-1 receptor agonists or weight loss medications may be considered
However, these treatments may indirectly affect B12 levels through slowed gastric emptying, reduced dietary intake due to appetite suppression, and interaction with concurrent metformin use, which is known to reduce B12 absorption
GLP-1 Support for Ozempic, Wegovy (pill and injectable), Rybelsus, and Orforglipron Stay organized and informed throughout your GLP-1 journey: - Reminders and dose tracking - Symptom and side effect logging - Clear history and progress charts Estimated Medication Levels Visualize how medication levels may change over time with interactive charts based on clinical pharmacokinetic datahelpful for daily planning and discussions with your clinician
